Table 1

Patient characteristics

Case Age/sex/duration Eye Initial VA Final VA Years of
follow up
Rx now Relapse Activity
free years
135/M/36L:R6/12:6/96/12:6/98.5YesOff Rx, at 6 years 2.5
244/M/72L:R6/7.5:2/606/6:2/606NoNo5
329/F/5 daysL:R 6/60:6/126/36:6/7.54.1NoNo10
434/M/7L:R6/5:6/56/6:6/12(N5)5.6YesMultiple 1
529/M/1L:R 6/5:6/56/6:6/63YesNo2.5
624/F/1L:R6/6:6/366/5:6/361.3YesNo1
744/M/2L:R6/6:6/606/6:6/602.4YesNo2
  • Duration = time between onset of disease and initiation of immunosuppression. Initial VA = Snellen visual acuity at initiation of immunosuppression. Final VA = Snellen visual acuity at last visit. Years of follow up = years of follow up since initiation of immunosuppression. Rx now = “Yes” if patient is still taking immunosuppressive drug, “No” if not. Relapse = “No” if there was no activity of disease at any follow up since initiation of immunosuppression. Activity free years = years of no detectable disease activity after initiation of immunosuppression.

  • Patient had been immunosuppressed for 6 years and on a low dose of cyclosporin at time of relapse. After increased dose, patient has been free of activity since.

  • Patient required unusually aggressive immunosuppression.